CD7 CAR-T cells for hard-to-treat autoimmune disease
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests a new cell therapy that uses your own immune cells to target and calm the overactive immune system causing your autoimmune disease. It is for people with systemic sclerosis that has not improved after at least two standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with systemic sclerosis (a condition where your immune system attacks your skin and organs).
- Your disease has not responded to at least two different immunosuppressive or biologic medications.
- Your bone marrow, blood clotting, liver, kidney, and heart/lung function are within acceptable ranges.
- You do not have a history of other cancers in the last 5 years (except certain skin cancers).
- You do not have active hepatitis B, AIDS, syphilis, or other serious viral infections.
- You do not have severe heart disease or serious mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using your own immune cells, modified to attack faulty cells that drive systemic sclerosis. It's for people with active disease who haven't improved with standard therapies.
This study tests a new type of immune cell therapy (CAR-T cells) designed to treat severe autoimmune diseases like rheumatoid arthritis, lupus, dermatomyositis, and scleroderma that haven't responded well to standard treatments. The therapy works by modifying your own immune cells to target and eliminate the B cells that are causing your autoimmune disease.
This trial tests a new treatment called PA3-17, which uses your own immune cells modified to target and kill cancer cells that have a protein called CD7 on them. It is designed for patients with T-cell leukemia or lymphoma that has come back or did not respond to prior treatments.
This trial uses your own engineered immune cells (CAR-T cells) to treat severe autoimmune diseases like rheumatoid arthritis, lupus, Sjögren's syndrome, or systemic sclerosis that haven't improved with standard medicines. The goal is to see if this treatment can calm the immune system and reduce disease activity.
This trial tests whether a special type of immune cell therapy, called CAR T-cells, can help people with severe systemic sclerosis (a disease causing skin and organ hardening) that hasn't improved with standard treatments. The goal is to see if it can stop the disease from getting worse.
This trial studies a type of immune cell therapy (CAR-T) made from your own T-cells, designed to treat T-cell lymphoma or T-cell leukemia that has come back or didn’t respond. It may help by directing your immune system to attack the cancer, and it requires specific eligibility and safety checks.
Hear when a new Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.